期刊文献+

异氟醚和依托咪酯对重症肌无力患者胸腺切除术Bcl-2的影响 被引量:2

Effect of Isoflurane and Etomidate on Serum Levels of Bcl-2 in Patients with Myasthenia Gravis Thymectomy
原文传递
导出
摘要 目的探讨异氟醚和依托咪酯对重症肌无力患者胸腺切除术血清Bcl-2的影响。方法 40例重症肌无力胸腺切除术患者,随机分为异氟醚组和依托咪酯组,每组20例。采用ELISA法检测患者术前、术后血清Bcl-2水平的变化。结果异氟醚组血清Bcl-2术后低于术前(P<0.01),依托咪酯组血清Bcl-2水平术后高于术前(P<0.01)。两组血清Bcl-2水平术前比较差异无统计学意义(P>0.05),术后血清Bcl-2水平依托咪酯组高于异氟醚组(P<0.01)。结论异氟醚用于重症肌无力患者麻醉可降低Bcl-2水平,而依托咪酯则升高Bcl-2水平,异氟醚可能比依托咪酯更适合用于重症肌无力患者胸腺切除术的麻醉。 OBJECTIVE To investigate the effect of isoflurane and etomidate on serum levels of Bcl-2 in patients with rnyasthenia gravis thymectomy. METHODS Forty patients with rnyasthenia gravis thymectomy were randomly divided into isoflurane group and etornidate group. The levels of Bcl-2 were measured at preoperative and postoperative with ELISA method. RESULTS The serum Bcl-2 levels postoperative were lower than preoperative in isoflurane group (P〈0.01). The serum Bcl-2 levels postoperative were higher than preoperative in etornidate group (P〈0.01). There was no significant difference of Bcl-2 serum levels between the two groups before surgery (P〉0.05). The Bcl-2 serum levels in etornidate group were higher than isoflurane group postoperative (P〈0.01). CONCLUSION Isoflurane can reduce the serum levels of Bcl-2 during thyrnectorny, while etornidate increases the level ofBcl-2. Isoflurane is more suitable than etomidate for patients with thyrnectomy.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2011年第8期774-776,共3页 Chinese Journal of Modern Applied Pharmacy
基金 郑州大学研究生科学研究基金项目(2009C3212)
关键词 重症肌无力 胸腺切除术 依托咪酯 异氟醚 myasthenia gravis thyrnectomy etornidate isoflurane
  • 相关文献

参考文献2

二级参考文献20

  • 1马铮,王如文,蒋耀光,赵云平.重症肌无力胸腺细胞凋亡与Fas基因表达的研究[J].第三军医大学学报,2004,26(17):1587-1589. 被引量:4
  • 2刘睿,李柱一,王桂平,杨浩,张琪,鞠躬.用AChR单克隆抗体建立大鼠重症肌无力被动转移模型的研究[J].中国神经免疫学和神经病学杂志,2005,12(2):79-82. 被引量:7
  • 3张旭,Mario Losen,Marc De Baets.抗乙酰胆碱受体单克隆抗体A7诱导实验性自身免疫性重症肌无力作用[J].中国神经免疫学和神经病学杂志,2005,12(2):83-85. 被引量:5
  • 4徐金枝,杨明山,吴昌杰,陈莉兰,顺碧.女性激素与重症肌无力关系的研究[J].中华神经科杂志,1996,29(6):351-353. 被引量:7
  • 5许贤豪.重症肌无力[M].北京:北京医科大学、中国协和医科大学出版社,1992.113-150.
  • 6Aarli JA. Late- onset myasthenia gravis: a changing scene .Arch Neurol, 1999,56(1 ) :25-27.
  • 7Marx A, Wilish A, Schultz A, et aL Expression of neurofilaments and of a titin epitope in thymic epithelial tumor: implications for the pathogenesis of myasthenia gravis. Am J Pathol, 1996, 148 : 1839-1850.
  • 8Hohlfeld R Myasthenia gravis and thymoma: paraneoplastic failure of neuromuscular transmission. Lab Invest, 1990, 62:241-242.
  • 9Chen FF, Yah JJ, Jin YT, et al. Detection of bcl-2 and p53 in thymoms : expression of Bcl-2 as a reliable marker of tumor aggressiveness. Hum Pathol, 1996, 27 : 1089-1092.
  • 10Salakou S, Tsamandas AC, Bonikos DS, et al. The potential role of bcl-2, bax, and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters. Eur J Cardiothorac Surg, 2001, 20:712-721.

共引文献15

同被引文献21

  • 1THARIN S, GOLBY A. Functional brain mapping and its applications to neurosurgery [J]. Neurosurgery, 2007, 60(4 Suppl 2): 185-202.
  • 2JONES H, SMITH M. Awake craniotomy [J]. Continuing Education in Anaesthesia, Critical Care & Pain, 2004, 4(6):189-192.
  • 3IMANI F, JAFARIAN A, HASSANI V, et al. Propofol-alfentanil vs propofol remifentanil for posterior spinal fusion including wake-up test [J]. Br J Anaesth, 2006, 96(5): 583-586.
  • 4ERICKSON K M, COLE D J. Anesthetic considerations for awake craniotomy for epilepsy [J]. Anesthesiol Clin, 2007, 25(3): 535-555.
  • 5ROZET I. Anesthesia for functional neurosurgery: the role of dexmedetomidine [J]. Curr Opin Anaesthesiol, 2008, 21(5): 537-543.
  • 6MARTORANO P P, ALOJ F, BAIETTA S, et al. Sufentanil-propofol vs remifentanil-propofol during total intravenous anesthesia for neuro-surgery: a multicentre study [J]. Minerva Anestesiol, 2008, 74(6): 233-243.
  • 7ELIZABETH A M, LEO H D. Anesthesia in the patient for awake craniotomy [J]. Cur Opin Anaesthesiol, 2007, 20(4): 331-335.
  • 8BEKKER A Y, KAUFMAN B, SAMIR H, et al. The use of dexmedetomidine infusion for awake craniotomy [J]. Anesth Analg, 2001, 92(5): 1251-1253.
  • 9HALL J E, UHRICH T D, BARNEY J A, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions [J]. Anesth Analg, 2000, 90(3): 699-705.
  • 10ARAIN S R, EBERT T J. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation [J]. Anesth Analg, 2002, 95(2): 461-466.

引证文献2

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部